DNA Script to present at the SynBioBeta conference in London
Paris | April 3, 2017

DNA Script, a company focused on the manufacturing of synthetic DNA using a proprietary enzymatic technology, will present at the Synbiobeta conference on Tuesday, April the 4th at 3.35 p.m. in London, UK. The Synbiobeta Conference is a financial investor and strategic business partnering event focused on early stage companies in the life science field.